Polymerized bovine hemoglobin solution as a replacement for allogeneic red blood cell transfusion after cardiac surgery: Results of a randomized, double-blind.

Slides:

Advertisements

Similar presentations

The coronary delivery of marrow stromal cells for myocardial regeneration: Pathophysiologic and therapeutic implications Jih-Shiuan Wang, MD, Dominique.

Advertisements

Resection of ascending aortic aneurysm without use of an interposition aortic graft John S. Ikonomidis, MD, PhD, FRCS(C), Abe DeAnda, MD, D.Craig Miller,

Enhancement of depsipeptide-mediated apoptosis of lung or esophageal cancer cells by flavopiridol: Activation of the mitochondria-dependent death-signaling.

Pathologic N1 non-small cell lung cancer: Correlation between pattern of lymphatic spread and prognosis Alessandro Marra, MD, PhD, Ludger Hillejan, MD,

Max B. Mitchell, MD The Journal of Thoracic and Cardiovascular Surgery

Lost in translation The Journal of Thoracic and Cardiovascular Surgery

Manuel J. Antunes, MD, PhD, DSc

Stephen R. Broderick, MD, MPHS

A wolf in sheep's clothing

Efficacy and safety of recombinant factor XIII on reducing blood transfusions in cardiac surgery: A randomized, placebo-controlled, multicenter clinical.

Implementation of a comprehensive blood conservation program can reduce blood use in a community cardiac surgery program Steve Xydas, MD, Christopher.

Reduced postoperative blood loss and transfusion requirement after beating-heart coronary operations: A prospective randomized study Raimondo Ascione,

CD133+ cells: How could they have an IMPACT?

Neel R. Sodha, MD, Frank W. Sellke, MD

The days of future past Neel K. Ranganath, MD, Aubrey C. Galloway, MD

Mitral surgery on the precipice of transformation

Thoracoscopic management of postoperative esophageal leak

Risk factors for early hospital readmission after cardiac operations

Same-day cancellation of cardiac surgery: A retrospective review at a large academic tertiary referral center Mark M. Smith, MD, William J. Mauermann,

Intrinsic cardiac stem cells are essential for regeneration

Victor van Berkel, MD, PhD

William M. DeCampli, MD, PhD

Off-Label Use of Recombinant Human Factor VIIa

Go on-pump or off-pump in diabetic patients?

Risk-corrected impact of mechanical versus bioprosthetic valves on long-term mortality after aortic valve replacement Ole Lund, MD, PhD, Martin Bland,

The lord of the rings Antonio Miceli, MD, PhD

Impact of Blood Product Transfusion on Short and Long-Term Survival After Cardiac Surgery: More Evidence Balu Bhaskar, MD, FCICM, Joel Dulhunty, PhD,

Who needs blood? The flip side of blood conservation

Juan N. Pulido, MD The Journal of Thoracic and Cardiovascular Surgery

Joshua W. Salvin, MD, MPH, Mark A. Scheurer, MD, Peter C

Support Your Specialty

Innovation and science: The future of valve design

It's not “just a shunt” but sometimes it should be…

A first start for lung transplantation?

Confusion still exists regarding postoperative delirium and its etiology after esophagectomy Robert B. Cameron, MD The Journal of Thoracic and Cardiovascular.

Stephen R. Broderick, MD, MPHS

Joseph A. Dearani, MD, Michael J. Ackerman, MD, PhD

Jeevanantham Rajeswaran, PhD, Eugene H. Blackstone, MD

S. Martens, MD, M. Dietrich, MD, M. Doss, MD, G

Niv Ad, MD, Lawrence M. Wei, MD

Marc Licker, MD, John Diaper, RA

The Ross procedure: Time to reevaluate the guidelines

Tranexamic acid in hip fracture surgery: a randomized controlled trial

Bobby Yanagawa, MD, PhD, Rodolfo V

Passing the torch The Journal of Thoracic and Cardiovascular Surgery

Mesenteric blood flow in patients with diabetic neuropathy

Transfusion outcomes in patients undergoing coronary artery bypass grafting treated with prasugrel or clopidogrel: TRITON-TIMI 38 retrospective data analysis

Functional tricuspid pathology: To treat or not to treat

The harder one looks, the more one finds

Research and research funding in vascular surgery

A phase 2 prospective, randomized, double-blind trial comparing the effects of tranexamic acid with ecallantide on blood loss from high-risk cardiac surgery.

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

Tai Ji: The law of inflammatory response

Tissue valve, nitinol stent, or storage solution

The future of cardiac surgery training: A survival guide

Commentary: “Isn't cardiac surgery a team sport?”

Ventricular assistant in restrictive cardiomyopathy: Making the right connection Robert D.B. Jaquiss, MD The Journal of Thoracic and Cardiovascular Surgery

Building a clinical program in a single institution

Vinay Badhwar, MD, John S. Ikonomidis, MD, PhD, Jeffrey P. Jacobs, MD

“The more things change…”: The challenges ahead

Commentary: Judgment day: Should you add atrial fibrillation ablation?

Managing conflicts of interest

First in line for robotic surgery: Would you want to know?

Aprotinin in primary valve replacement and reconstruction: A multicenter, double-blind, placebo-controlled trial Michael N. D'Ambra, MD, Cary W. Akins,

Lung cancer randomized controlled trials should compare stereotactic body radiation therapy with observation, NOT surgery Raja M. Flores, MD The Journal.

Did you like Terminator 3 better than Terminator 2

Samuel Kim, MD The Journal of Thoracic and Cardiovascular Surgery

Akiko Tanaka, MD, PhD, Takeyoshi Ota, MD, PhD

Paul Philipp Heinisch, MD, Thierry Carrel, MD

Presentation transcript:

Polymerized bovine hemoglobin solution as a replacement for allogeneic red blood cell transfusion after cardiac surgery: Results of a randomized, double-blind trial Jerrold H. Levy, MD, Lawrence T. Goodnough, MD, Philip E. Greilich, MD, Grant V.S. Parr, MD, Robert W. Stewart, MD, Irwin Gratz, DO, Joyce Wahr, MD, John Williams, MD, Mark E. Comunale, MD, Dennis Doblar, PhD, MD, George Silvay, MD, Marc Cohen, MD, Jonathan S. Jahr, MD, Gus J. Vlahakes, MD The Journal of Thoracic and Cardiovascular Surgery Volume 124, Issue 1, Pages 35-42 (July 2002) DOI: 10.1067/mtc.2002.121505 Copyright © 2002 American Association for Thoracic Surgery Terms and Conditions

Fig. 1 Study protocol. Study-related procedures and monitoring, from screening through follow-up, are depicted. The Journal of Thoracic and Cardiovascular Surgery 2002 124, 35-42DOI: (10.1067/mtc.2002.121505) Copyright © 2002 American Association for Thoracic Surgery Terms and Conditions

Fig. 2 Serial hematocrit (A) and hemoglobin (B) measurements for patients in HBOC and RBC groups. The Journal of Thoracic and Cardiovascular Surgery 2002 124, 35-42DOI: (10.1067/mtc.2002.121505) Copyright © 2002 American Association for Thoracic Surgery Terms and Conditions

Fig. 3 Proportions of patients remaining hospitalized in terms of days after cardiac surgery for HBOC and RBC groups. Hospital stays were similar (P =.29). The Journal of Thoracic and Cardiovascular Surgery 2002 124, 35-42DOI: (10.1067/mtc.2002.121505) Copyright © 2002 American Association for Thoracic Surgery Terms and Conditions